INTRATUS

Serial Number 88446393
602

Registration Progress

Application Filed
May 24, 2019
Under Examination
May 26, 2020
Approved for Publication
Mar 31, 2020
Published for Opposition
Mar 31, 2020
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: INTRATUS
Previous Owner: Intratus, Inc.
Classes: 001, 003, 005, 010, 025, 041, 042, 044

Trademark Image

INTRATUS

Basic Information

Serial Number
88446393
Filing Date
May 24, 2019
Published for Opposition
March 31, 2020
Abandonment Date
April 13, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Apr 4, 2025
Classes
001 003 005 010
+4 more

Rights Holder

Intratus, Inc.

03
Address
5330 Carroll Canyon Road, Suite 200
San Diego, CA 92121

Ownership History

Intratus, Inc.

Original Applicant
03
San Diego, CA

Intratus, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Katharine Tremblay

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

50 events
Date Code Type Description Documents
Apr 4, 2025 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Apr 4, 2025 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Oct 16, 2024 ATRV O ATTORNEY REVIEW COMPLETED Loading...
Jan 6, 2022 ATRQ I ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED Loading...
Jan 6, 2022 PR.D T PETITION TO REVIVE DISMISSED Loading...
Jan 6, 2022 APET A ASSIGNED TO PETITION STAFF Loading...
Nov 27, 2021 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Nov 26, 2021 PETR I PETITION TO REVIVE-RECEIVED Loading...
Nov 26, 2021 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Nov 26, 2021 PETG O PETITION TO REVIVE-GRANTED Loading...
Nov 26, 2021 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Nov 26, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 12, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 12, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 12, 2021 CNFR W SU - FINAL REFUSAL - WRITTEN Loading...
Sep 16, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 16, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 16, 2021 ALIE A ASSIGNED TO LIE Loading...
Sep 12, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 13, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 13, 2021 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 13, 2021 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Feb 23, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 21, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 1, 2021 IUAF S USE AMENDMENT FILED Loading...
Feb 21, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 27, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 21, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 1, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 2, 2021 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Feb 1, 2021 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Feb 1, 2021 PETG O PETITION TO REVIVE-GRANTED Loading...
Feb 1, 2021 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Dec 28, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 28, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 26, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 31, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 31, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 11, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 24, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 22, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 22, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 21, 2020 ALIE A ASSIGNED TO LIE Loading...
Feb 16, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 16, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 16, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 16, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 15, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...

Detailed Classifications

Class 001
Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Plant extracts for use in the manufacture of creams, lotions and cosmetic products
Class 003
Cosmetics
Class 005
Anesthetics for non-surgical use; Balms for medical purposes; Balms for pharmaceutical purposes; Chemical preparations for pharmaceutical and medical purposes, namely, for Ophthalmology, Allergy and Immunology, Cardiovascular, and Type II Diabetes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of emollients that facilitate the delivery of pharmaceutical preparations; Emollients for medical purposes; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for ocular and intraocular surgery; Pharmaceutical preparations for the treatment and prevention of dry eye and glaucoma and other ocular disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention of dry eye; Pharmaceutical preparations for the treatment of ocular disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for ophthalmic conditions, allergies, immune system diseases, cardiovascular, and type II diabetes; Plant extracts for medical, veterinary and pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for ophthalmological use; Topical anesthetics
Class 010
Drug delivery systems; Medical devices for nonsurgical cosmetic treatments; Medical apparatus for introducing pharmaceutical preparations into the human body
Class 025
Hats; Hoodies; Jackets; Shirts; Sweatshirts; Wearable garments and clothing, namely, shirts
Class 041
Continuing education services, namely, providing live and on-line continuing professional education seminars in the field of medicine and more specifically those fields of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes as they relate to current treatments; Continuing education services, namely, providing live and on-line continuing professional education seminars in the legal, medical, accounting, and real estate fields; Education services, namely, providing tutorial sessions in the fields of medicine and more specifically those fields of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes as they relate to current treatments; Providing continuing medical education courses
Class 042
Clinical research in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Medical research; Medical and scientific research in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of technology in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Scientific research for medical purposes in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Biochemical research and development; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Pharmaceutical research and development
Class 044
Clinical medical practice consultation services; Medical clinic services; Medical services; Ophthalmology services; Medical treatment of dry eye and or glaucoma and other ocular disorders; Medical diagnosis and treatment of dry eye and or glaucoma and other ocular disorders

Classification

International Classes
001 003 005 010 025 041 042 044